Esperion Therapeutics, Inc.: accounts_payable
| Value | {"amount": 20375000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ff53215e-e55a-41af-be84-fa0df8a3c063
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-18-000899Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/accounts-payable/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ff53215e-e55a-41af-be84-fa0df8a3c063
History
- no predecessors — first report